Netupitant with palonosetron (Akynzeo®) for nausea and vomiting associated with moderately emetogenic cytotoxic chemotherapy

Page last updated: 1 June 2017

From 1 June 2017 netupitant with palonosetron will be listed for nausea and vomiting associated with moderately emetogenic chemotherapy where the patient has experienced a prior episode of chemotherapy induced nausea or vomiting.